Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an ...

When he was five years old, Malcolm Barlow arrived at a country estate in Pennsylvania to escape World War II. He never left, ...

Topline results from the groundbreaking Salford Lung Study are encouraging for GSK's new respiratory drug - but the 'real world' story isn't quite so simple. GlaxoSmithKline (GSK) has announced ...

US. They provide convincing evidence to support their conclusion that using the whole genome, rather than previous use of two surface proteins, enhances our understanding of strain-specific vaccine ...

iTeos Therapeutics has said it is evaluating with partner GlaxoSmithKline whether to conduct ... but iTeos said it is committed with GSK to completing their already-planned trials of EOS-448.

BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by ...

is Rs 1842.05 Glaxosmithkline Pharmaceuticals Ltd, incorporated in the year 1924, has its registered office in GSK House, Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030, 91-022-24959595 ...

Uganda has launched a malaria vaccination campaign in Apac District, northern Uganda. This makes Uganda the 19th country in Africa to introduce the malaria vaccine into routine immunisation, and it ...